Download presentation
Presentation is loading. Please wait.
Published byAde Kusumo Modified over 5 years ago
1
Effect of lipid-modifying drug therapy on survival after abdominal aortic aneurysm repair
Gaurav M. Parmar, MD, MPH, Bruce Lowman, MD, Bart R. Combs, MD, Steve M. Taylor, MD, Mark A. Patterson, MD, Marc A. Passman, MD, William D. Jordan, MD, FACS Journal of Vascular Surgery Volume 58, Issue 2, Pages (August 2013) DOI: /j.jvs Copyright © 2013 Society for Vascular Surgery Terms and Conditions
2
Fig 1 Identification of eligible study participants.
Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
3
Fig 2 a, Survival from aneurysm-related mortality (n = 82). b, Survival from cardiovascular mortality (n = 131). c, Survival from all-cause mortality (n = 656). LMDT, Lipid-modifying drug therapy; SE, standard error. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
4
Fig 3 Multivariable adjusted hazard ratios with 95% confidence intervals (CIs) from Cox proportional hazard regression. EVAR, Endovascular repair; LMDT, lipid-modifying drug therapy; OADD, other atherosclerotic diseases or diabetes. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.